Showing results (171-180 of 389) with videos related to
Sort By:
Pageof 39
Endocrine-Related Cancer|February 16, 2022
Prognostic significance of hyperammonemia in neuroendocrine neoplasm patients with liver metastasesJulie Refardt, Caroline M den Hoed, Janneke Langendonk, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 4, 2006
Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanomaMartijn van Essen, Eric P Krenning, Peter P Kooij, et al.The Journal of Clinical Endocrinology and Metabolism|June 8, 2000
Five patients with biochemical and/or clinical generalized glucocorticoid resistance without alterations in the glucocorticoid receptor geneN A Huizenga, P de Lange, J W Koper, et al.Nederlands Tijdschrift Voor Geneeskunde|September 1, 2005
[Adrenal incidentaloma: a clinical problem related to imaging]E L E de Bruijne, J P J Burgmans, G P Krestin, et al.Cancers|January 28, 2021
Evolution of the Mesenteric Mass in Small Intestinal Neuroendocrine TumoursAnela Blažević, Tessa Brabander, Wouter T Zandee, et al.European Journal of Cancer (Oxford, England : 1990)|December 15, 2023
Midgut neuroendocrine tumor patients have a depleted gut microbiome with a discriminative signatureM C F Mulders, A S Audhoe, P M Van Koetsveld, et al.Trials|January 16, 2024
Methodology of the SORENTO clinical trial: a prospective, randomised, active-controlled phase 3 trial assessing the efficacy and safety of high exposure octreotide subcutaneous depot (CAM2029) in patients with GEP-NETSimron Singh, Diego Ferone, Jaume Capdevila, et al.Endocrine Connections|May 25, 2016
Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?Roxanne C S van Adrichem, Aart Jan van der Lely, Martin Huisman, et al.Endocrine-Related Cancer|October 8, 2020
Inferior outcome of neuroendocrine tumor patients negative on somatostatin receptor imagingJulie Refardt, Wouter T Zandee, Tessa Brabander, et al.Clinical Endocrinology|December 1, 1996
In vivo imaging of pituitary tumours using a radiolabelled dopamine D2 receptor radioligandW W de Herder, A E Reijs, D J Kwekkeboom, et al.Pageof 39